Davis, California Feb 23, 2016 – Evolve BioSystems, Inc., a mid-stage microbiome company developing the next generation of products to establish, restore, and maintain a healthy human gut microbiome, is pleased to announce that Evolve CEO, Dr. David Kyle, will be presenting at the 3rd Microbiome R&D and Business Collaboration Congress: Asia, which will be held on March 1 – 2, 2017 in Hong Kong.
The conference will bring together Pharma, Biotech, Academic Institutions and investors who are partnering together to develop and progress ground-breaking microbiome research into commercially viable products.
Dr. Kyle will be speaking in a special Solution Provider Presentation section of the program, providing valuable insights into the critical role of the infant gut microbiome in his talk titled, “The Infant Gut Microbiome: From Dysbiosis to Recovery.”
For more details on the Microbiome R&D and Business Collaboration Congress: Asia, please visit: http://www.global-engage.com/event/microbiome-asia/#speakers
To learn more about Evolve BioSystems, visit: www.evolvebiosystems.com
Tracy Shafizadeh, PhD
Director, Scientific Communications